Iodine-131

CEA cell adhesion molecule 3 ; Homo sapiens







58 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 20078028 Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. 2010 Feb 17 2
2 11877768 Radioimmunotherapy of small-volume disease of metastatic colorectal cancer. 2002 Feb 15 1
3 9466665 Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer. 1998 Feb 9 3
4 9615730 Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases. 1998 Mar-Apr 2
5 9716032 Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy. 1998 Aug 1
6 9025751 Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody. 1997 Feb 1
7 9074529 Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. 1997 Mar 1
8 9189130 Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. 1997 Jun 1
9 9393755 Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. 1997 Dec 1 1
10 9406734 Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies. 1997 Dec 15 5
11 8656248 Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics. 1996 Jun 1
12 8683309 Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. 1996 Jun 2
13 8790202 Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. 1996 Sep 1
14 7812699 Detection of lymph node metastases in lung cancer: comparison of 131I-anti-CEA-anti-CA 19-9 immunoscintigraphy versus computed tomography. 1994 Sep 1
15 8080740 Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies. 1994 Sep 2
16 8204403 Radioimmunoscintigraphy of CEA/CA 19-9 producing tumors with I-131 labeled monoclonal antibodies. 1994 Feb 1
17 8277212 Radioimmunotherapy of gastrointestinal cancer and glioblastomas. 1993 Jul-Sep 1
18 8384868 Radioimmunodetection of lung cancer with IMACIS-1, I-131 labeled monoclonal antibodies to CEA and CA19-9. Comparison of accumulations in irradiated and non-irradiated site. 1993 Feb 1
19 8518021 Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues. 1993 1
20 1322378 Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas. 1992 Jul 30 1
21 1451056 Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice. 1992 Dec 15 1
22 1464034 [Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential]. 1992 Jun 1
23 1657845 Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma. 1991 Nov 2
24 1995488 The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft model. 1991 Feb 20 1
25 2004846 A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. 1991 Mar 12 1
26 2010308 Qualitative and quantitative kinetics of submucosally administered antibody fragments in patients with rectal carcinoma: the detection of lymph node metastasis in relation to local tracer diffusion. 1991 1
27 2231001 Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report. 1990 Nov 1
28 2639132 Localization of metastases from medullary thyroid carcinoma using different methods. 1989 1
29 2655889 Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study. 1989 Jun 1 1
30 2715009 Role of 131I-labelled anti-CEA/CA 19-9 monoclonal antibodies in the diagnosis and follow-up of gastrointestinal tumors. 1989 1
31 2789951 Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. 1989 Sep 4
32 12412766 Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies. 1989 Nov 1
33 3048746 Radioimmunodetection of cancer with monoclonal antibodies: current status, problems, and future directions. 1988 2
34 3209304 Biodistribution of 131I-labelled monoclonal antibodies in human colon tumours by an ex vivo perfusion model. 1988 1
35 3217256 [Radioimmunotherapy of solitary liver metastases using intratumor instillation of 131I-labeled monoclonal antibodies--initial results of a clinical study]. 1988 Dec 1
36 3235853 Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study. 1988 Oct-Dec 1
37 3258293 Quantitation in 131I-radioimmunotherapy using SPECT. 1988 2
38 3335416 Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model. 1988 Jan 15 2
39 3032877 Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study. 1987 May 1
40 3449789 Antibody-guided irradiation of hepatic metastases using intrahepatically administered radiolabelled anti-CEA antibodies with simultaneous and reversible hepatic blood flow stasis using biodegradable starch microspheres. 1987 Dec 3
41 3501573 [Radioimmunoscintigraphy using SPECT: methodology, problems and clinical experiences]. 1987 Oct 1
42 3548950 Relationship of radioantibody localization and cell viability in a xenografted human cancer model as measured by whole-body autoradiography. 1987 Apr 15 2
43 3622555 Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer. 1987 1
44 3677890 [Current role of immunoscintigraphy for surgical therapy of the recurrence of colorectal cancers]. 1987 Sep 1
45 3821910 Evaluation of immunolocalization in gastrointestinal cancer. 1987 1
46 3713682 [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma]. 1986 Mar 1
47 3820841 [Enhanced binding of 131I-labeled monoclonal anti-CEA antibody to a CEA producing lung carcinoma cell line (QG56) after phorbol ester (TPA) treatment]. 1986 Oct 2
48 3867855 [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125]. 1985 Dec 1
49 4075656 Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma. 1985 Oct 3
50 6085756 Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancers. 1984 Fall 2